Paul R Edick
CIK 1531178 · See Remarks · last filed 2025-11-04
Paul R Edick is a corporate insider who has filed 51 SEC Form 4 insider transactions across 9 companies since 2011. The most recent filing, for VTGN, was dated Nov 4, 2025. Across all open-market trades the lifetime net is +$1.4M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $25.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$25.95M
9
51
$1.37M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VTGN | Director | — | $0.58 | — | $0 | 1 | 2025-11-04 |
| XERS | See Remarks | 3,821,494 | $6.79 | $25.95M | $1.30M | 19 | 2024-01-31 |
| MIST | Director | — | $1.27 | — | $0 | 1 | 2020-06-08 |
| Iterum Therapeutics plc (ITRM) Delisted | Director | 31,390 | $0.03 | $942 | $5.2K | 4 | 2019-05-29 |
| PDL BIOPHARMA, INC. (PDLI) Delisted | Director | 214,563 | — | — | $0 | 4 | 2018-06-12 |
| Sucampo Pharmaceuticals, Inc. (SCMP) Delisted | Director | 0 | — | — | $0 | 4 | 2018-02-13 |
| Neos Therapeutics, Inc. (NEOS) Delisted | Director | — | $1.15 | — | $0 | 2 | 2017-07-05 |
| LUMOS PHARMA, INC. (NLNK) Delisted | Director | 7,906 | — | — | $0 | 10 | 2017-05-16 |
| Durata Therapeutics, Inc. (DRTX) Delisted | Chief Executive Officer | 24,636 | — | — | $64.5K | 5 | 2014-11-18 |
Recent Filings
51 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-04 | VTGN | Grant (A) | — | $0 | EDGAR |
| 2024-01-31 | XERS | Grant (A) | +1,500,000 | $0 | EDGAR |
| 2023-08-09 | XERS | Buy (P) | +10,000 | $23.8K | EDGAR |
| 2023-02-01 | XERS | Grant (A) | +750,000 | $0 | EDGAR |
| 2022-12-14 | XERS | Buy (P) | +20,000 | $29.0K | EDGAR |
| 2022-05-13 | XERS | Buy (P) | +100,000 | $140.4K | EDGAR |
| 2022-01-05 | XERS | Grant (A) | +600,000 | $0 | EDGAR |
| 2021-11-16 | XERS | Buy (P) | +20,000 | $45.7K | EDGAR |
| 2021-11-12 | XERS | Buy (P) | +200,000 | $415.8K | EDGAR |
| 2021-10-05 | XERS | Disp (D) | −621,494 | $0 | EDGAR |